ライフサイエンスコーパス: clinical presentation

1 ography with or without CMR according to the clinical presentation.

2 he relevance of their brain malformations to clinical presentation.

3 rder of diagnostic evaluations, depending on clinical presentation.

4 transplantation allocation who have the same clinical presentation.

5 fferential diagnosis in the case of atypical clinical presentation.

6 relatives ascertained independently through clinical presentation.

7 eatable acquired causes for this imaging and clinical presentation.

8 by frailty, 2-year vaccination history, and clinical presentation.

9 3,000, is characterized by a highly variable clinical presentation.

10 nal spectrum of this gene and the associated clinical presentation.

11 r Barth syndrome, which shows disparities in clinical presentation.

12 n affecting various organs and has a diverse clinical presentation.

13 cy of certain treatments might depend on the clinical presentation.

14 istinct in their histological, molecular and clinical presentation.

15 al dysfunction biomarkers were determined at clinical presentation.

16 r results highlight that rtvFTD has a unique clinical presentation.

17 tures from >200 serum samples collected upon clinical presentation.

18 nset spastic movement disorder with variable clinical presentation.

19 ted as being inconsistent with the patient's clinical presentation.

20 ing the pathogenesis and the highly variable clinical presentation.

21 d help us to understand the heterogeneity of clinical presentations.

22 toxin and its NTS ortholog induce different clinical presentations.

23 es investigation between lineage and diverse clinical presentations.

24 Patients present with varied and nonspecific clinical presentations.

25 quence analysis of genetically heterogeneous clinical presentations.

26 those detected in patients with less severe clinical presentations.

27 wo diseases share common origins with varied clinical presentations.

28 ria for PNSs and examine their frequency and clinical presentations.

29 ered "phenotypes" to specific mechanisms and clinical presentations.

30 compared to assess demographic variables and clinical presentations.

31 in schizophrenia including heterogeneity in clinical presentations.

32 defect as there was considerable overlap in clinical presentations.

33 ny of the three human genes leads to similar clinical presentations.

34 re, autosomal dominant disease with variable clinical presentations.

35 aorbital metallic foreign bodies have varied clinical presentations.

36 of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protecti

37 A predominance of females (62%), classical clinical presentation (86%) and positive anti-transgluta

38 pneumoniae genotype shift and its impact on clinical presentations, additional surveillance programs

39 ch recruited unselected (ie, irrespective of clinical presentation) adult (aged >=18 years) patients

40 We reviewed the literature on clinical presentation, aetiology and diagnostic approach

41 e the changes in the spectrum of IPD and its clinical presentations after 13-valent PCV (PCV13) imple

42 aphy and blood gas analysis within 48 h from clinical presentation, after 1 wk, and after 1, 6, and 1

43 ted illness among individuals with different clinical presentations (all-respiratory, all-circulatory

44 that is, the 3 PVN disease classes predicted clinical presentation, allograft function, and outcome i

45 Meningitis was the most common clinical presentation among <1 year olds (71.4%); bacter

46 ebral hemorrhagic lesions with a more severe clinical presentation and a higher admission rate in int

47 AS-CA has worse clinical presentation and a trend toward worse prognosis

48 ent of HAA is highly variable and depends on clinical presentation and anatomic location.

49 ebral artery injury (TVAI) can have a varied clinical presentation and appearance on imaging.

50 o LDL-C explain some of the heterogeneity in clinical presentation and ASCVD risk for individuals wit

51 ansformation and accounts for the extranodal clinical presentation and biology of these tumors.

52 se the risk of CAD, but they also modify its clinical presentation and cardinal symptoms.

53 Substantial overlap exists in the clinical presentation and comorbidities among patients w

54 The clinical presentation and course of the disorder have be

55 nt understanding of the pathology, genetics, clinical presentation and diagnosis of DLB; options for

56 management of GBS can be complicated as its clinical presentation and disease course are heterogeneo

57 can be made by the combination of a typical clinical presentation and evidence of nut specifc IgE sh

58 KTR with CHIKV infection have a clinical presentation and evolution similar to those see

59 er in infancy and extremely heterogeneous in clinical presentation and features.

60 Lyme-epidemic area, highlighting changes in clinical presentation and healthcare use over time.

61 We sought to determine the clinical presentation and healthcare use patterns for pe

62 The diagnosis is based on clinical presentation and history, the characteristics o

63 al skin test responses inconsistent with the clinical presentation and in severe reactions in which d

64 Diagnosis of CDI relies on the assessment of clinical presentation and laboratory tests.

65 Here, we describe the clinical presentation and management of 25 adult patient

66 This study examined clinical presentation and management of a cohort of febr

67 of the study was is to evaluate the various clinical presentation and management of FC, IBS-C and NR

68 thus have profound indirect consequences on clinical presentation and management of patients with ST

69 s will require stratification based on their clinical presentation and mechanism of their mutations.

70 QB1*02 seems to be associated with classical clinical presentation and more severe histological damag

71 tion of empirical antibiotic agents based on clinical presentation and other risk factors.

72 To describe the clinical presentation and outcomes of patients with ICU-

73 ariety of causes with heterogeneity in their clinical presentation and outcomes.

74 although the remarkable heterogeneity of its clinical presentation and poor treatment response demand

75 onsensus-based treatment algorithm, based on clinical presentation and potential disease mechanisms.

76 antimicrobial therapy depends on severity of clinical presentation and presence or absence of associa

77 ith in vivo post-natal molecular, neural and clinical presentation and progression in each ASD child.

78 ns enrolled in clinical trials were based on clinical presentation and rarely included precision-medi

79 s an influence of HLA-DQB1*02 gene dosage on clinical presentation and severity of histological damag

80 o identify the bacterial factors involved in clinical presentation and severity of IMD-W cc11.

81 heir composition, which has an impact on the clinical presentation and the underlying disease that tr

82 iopathies that share several similarities in clinical presentation and vascular pathology.

83 retrospective cohort study, we describe the clinical presentation and workup of parathyroid carcinom

84 ory including transplantation history, their clinical presentation and workup, and their course from

85 ents with NSF diagnosis on the basis of both clinical presentations and biopsy confirmation were incl

86 ter understand the relationships between the clinical presentations and brain structure and function

87 ] 58 yr [44, 69] vs 70 [52, 78]; p < 0.001), clinical presentations and comorbidities overlapped subs

88 es in the clinical setting because of varied clinical presentations and delay in obtaining antibody p

89 a decision-tree model to predict a range of clinical presentations and economic outcomes under vacci

90 ghts these advances have provided into their clinical presentations and evolution.

91 ocardial signaling pathways, despite similar clinical presentations and findings, in patients with HF

92 ast four subtypes, which are correlated with clinical presentations and genetic causes.

93 e markedly different outcomes belied similar clinical presentations and histology and, in one cohort,

94 heir parents) with detailed records of their clinical presentations and identified a risk gene, ASH1L

95 in patients affected by CdCs with different clinical presentations and identify possible "brain meta

96 G metabolism in CDCS patients with different clinical presentations and identify possible brain metab

97 Response intervals, clinical presentations and indications for attempting re

98 and prognostic clarity to the heterogeneous clinical presentations and natural histories of advSM.

99 istry to generate a comprehensive picture of clinical presentations and outcome of patients with Dano

100 the differential impact of this pandemic on clinical presentations and outcomes in African Americans

101 The working group deliberated on the clinical presentations and used a 3-pronged approach to

102 d for a median of 4.4 years, many from first clinical presentation, and 106 scans of 80 healthy paedi

103 analyzing procedural numbers, changes in the clinical presentation, and characteristics of patients a

104 syncytial virus (RSV) genotype distribution, clinical presentation, and disease severity in infants w

105 Patient demographic data, clinical presentation, and ED and hospital management pr

106 n conjunction with patient exposure history, clinical presentation, and other laboratory findings.

107 because of their distinct etiologic factors, clinical presentation, and outcomes.

108 Differences in seasonality, clinical presentation, and prevalence between the differ

109 ncephalitis based on HHV-6 detection in CSF, clinical presentation, and radiographic findings.

110 ria, using only data obtained at the time of clinical presentation, and then to identify their mechan

111 Baseline characteristics, clinical presentation, antiviral and immunosuppressive m

112 rally generalizable measures accessible upon clinical presentation are effective predictors of COVID-

113 MOGAD patients differ in the clinical presentation at onset, showing an age-related s

114 te the relationship between pathological and clinical presentation at single symptom level, including

115 nosis, building on a largely morphology- and clinical presentation-based strategy.

116 molecular findings in the context of patient clinical presentations because accurate interpretation o

117 However, no significant differences in clinical presentation, BP severity scores, or autoantibo

118 ndrome, which can manifest with a variety of clinical presentations but often presents as an acute ca

119 In current usage 'concussion' describes a clinical presentation, but does not identify the underly

120 evelop severe neurological deficits, but the clinical presentation can also be mild with onset of sym

121 tipation, change in voice, and dry skin, but clinical presentation can differ with age and sex, among

122 Measuring sTREM-1 at clinical presentation can identify febrile individuals a

123 Clinical presentation can vary from abscess formation to

124 entiation from other infections with similar clinical presentations can be challenging, which can lea

125 ne if S. stercoralis co-infection influenced clinical presentation, cerebrospinal fluid (CSF) inflamm

126 is is based on an accurate exposure history, clinical presentation, characteristic high-resolution CT

127 This case series describes the clinical presentation, characteristics, and outcomes of

128 ents with EVALI typically have a nonspecific clinical presentation characterized by a combination of

129 ing from the gene mutations leads to similar clinical presentations, characterized by increased susce

130 We retrospectively reviewed clinical presentation, chemotherapy regimens, hematologi

131 We aimed to understand the infection rate, clinical presentation, clinical outcomes, and transmissi

132 rences in the epidemiology, pathophysiology, clinical presentation, clinical treatment, and clinical

133 d March 2020 were reviewed for demographics, clinical presentation, comorbidities, and surgeries perf

134 or HHV-6 by FA-ME was performed to determine clinical presentation, comorbidity, treatment, and outco

135 out descriptive analyses that summarized the clinical presentation, complications, and outcomes of pa

136 The ACS clinical presentation consisted of non-ST-segment-elevat

137 Clinical presentation consisted of palpable pulsatile ma

138 ed in only two individuals, both of whom had clinical presentations consistent with LB.

139 coronavirus 2 (SARS-CoV-2) and its resultant clinical presentation, coronavirus disease 2019 (COVID-1

140 males and females exhibiting differences in clinical presentation, course, and response to antidepre

141 ual dimorphisms, will aid recognition of the clinical presentation, development of biomarkers suitabl

142 , awareness needs to be raised regarding the clinical presentation, diagnosis and management of these

143 Owing to the multifaceted clinical presentation, diagnosis remains a challenge and

144 The epidemiology, risk factors, clinical presentation, diagnosis, and treatment of histo

145 iseases that vary according to pathogenesis, clinical presentation, diagnostic evaluation and criteri

146 roperitoneal fetus in fetu and discusses its clinical presentation, differential diagnosis and embryo

147 ts is unknown, and it is unclear whether the clinical presentation differs between patients positive

148 severe disease, little is known about their clinical presentation, disease course, or outcomes.

149 e subjects for which UPD was associated with clinical presentation due to imprinting disorders or rec

150 ngue illness, which may contribute to milder clinical presentation during coinfection.

151 nt disability is caused by both the dominant clinical presentation, e.g. paralysis or tremor and addi

152 l acuity (BCVA), intraocular pressure (IOP), clinical presentation, eye culture results, and treatmen

153 based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomat

154 CTE was not associated with a different clinical presentation from AD or with greater cognitive

155 ently evaluated for sex-based differences in clinical presentation, functional impairments, managemen

156 Diagnosis is typically based on clinical presentation (gastrointestinal symptoms and inf

157 ameters; however, these diseases have unique clinical presentations, genetics, and available therapie

158 ement guidelines based on histopathology and clinical presentation, genomic classification enables ea

159 mutations, and more in-depth observations of clinical presentations have clarified some issues even a

160 THODS AND Myocarditis was diagnosed based on clinical presentation, high-sensitivity troponin T, and

161 of lesions that differ with regard to their clinical presentations, histologic features, biomarker p

162 Clinical presentations, histopathologic features, labora

163 feasibility, and acceptability.Results: The clinical presentation, histopathology, and exclusion of

164 we collected information on the demography, clinical presentation, hospitalization, contact network

165 es tremendous interest due to its aggressive clinical presentation in a uniquely vulnerable host, its

166 solated optic neuritis was the most frequent clinical presentation in both children (40.8%) and adult

167 infection on inflammatory amplification and clinical presentation in dengue.

168 between topography of neurodegeneration and clinical presentation in DLB patients.

169 Atopic dermatitis (AD) shows differential clinical presentation in older compared with younger pat

170 d using PCP PCR alone or in conjunction with clinical presentation in PCP PCR-positive patients.

171 This study investigated the clinical presentation in relation to mutations in a larg

172 Clinical presentation in three of the four patients is r

173 osis may, in part, explain the prothrombotic clinical presentations in COVID-19, and NETs may represe

174 we are still learning more about the myriad clinical presentations in these severely affected childr

175 = 6.53; 95% CI: 1.16 to 36.72) had the worst clinical presentation including cardiovascular and sever

176 microdeletion in humans, with a heterogenous clinical presentation including medical, behavioural and

177 g conditions and were able to induce all IPD clinical presentations including bacteremic pneumonia.

178 ntial aetiologies of spine pain with similar clinical presentation, including degenerative changes, i

179 rmline variation in PTEN results in variable clinical presentations, including benign and malignant n

180 anguage abilities with three main phenotypic clinical presentations, including logopenic, non-fluent/

181 omplex have been associated with overlapping clinical presentations, indicating shared and distinct f

182 While both have similar clinical presentations, individuals with symptomatic pri

183 Clinical presentation, initial management decisions, and

184 Materials and Methods The demographics, clinical presentation, injuries, and radiologic findings

185 were studied and data regarding demography, clinical presentations, interventions received, and fina

186 les to be most significantly associated with clinical presentation: intrarenal polyomavirus load leve

187 More rarely, the clinical presentation is characterised by non-length-dep

188 The clinical presentation is extremely variable; patients ma

189 fection diagnosis is challenging because the clinical presentation is frequently misleading and echoc

190 tly represents a diagnostic challenge as the clinical presentation is often blurred by concomitant au

191 Although the predominant clinical presentation is with respiratory disease, neuro

192 Because of the heterogeneity of frailty in clinical presentation, it is important to have effective

193 In conjunction with the clinical presentation, laboratory findings, and epidemio

194 random forest, we analyzed the link between clinical presentation, laboratory results, outcome and e

195 Clinical presentation, laboratory values, immunosuppress

196 gestion and its wide spectrum of nonspecific clinical presentations makes dietary FB perforation extr

197 carcinoma consortium aiming to describe the clinical presentation, management, and outcomes of patie

198 orm was used to record data on demographics, clinical presentation, management, diagnosis, outcomes a

199 Thus, already at the time of initial clinical presentation, many patients with cancer harbor

200 ividuals with the same disease and a similar clinical presentation may have very different outcomes a

201 5.4% vs 45.1%; P = .005) and had less severe clinical presentations (median Pitt score, 0 [interquart

202 Each episode had unique features in terms of clinical presentation, microbial documentation, location

203 this disease, including pathophysiology and clinical presentation, moving on to diagnostic and treat

204 e purpose of this study was to determine the clinical presentation, myocardial perfusion on provocati

205 ent a large case series of ISCMs to describe clinical presentation, natural history and outcomes of b

206 The clinical presentation of a C. sativa allergy varies from

207 These findings are relevant to the clinical presentation of acetaminophen-hepatotoxicity an

208 To explore the differences in clinical presentation of acute flaccid myelitis, we also

209 ults with a cancer diagnosis, understand the clinical presentation of adult patients with cancer in t

210 d, soluble misfolded, soluble total) and the clinical presentation of ALS in the SOD1(G93A) mouse.

211 ant may be required in MSM, given the severe clinical presentation of associated diseases.

212 d arginine (Arg) is a common TME hallmark at clinical presentation of cancer.

213 us G960R mutation in NFKB1 leads to a severe clinical presentation of combined immunodeficiency.

214 The clinical presentation of COVID-19 is fairly nonspecific,

215 The heterogeneous aetiology and clinical presentation of DCM make a correct and timely d

216 The clinical presentation of flaccid and often profound musc

217 The clinical presentation of giant cell arteritis is occasio

218 ty measures, providing new insights into the clinical presentation of IBS.

219 with diagnosis, as well as the heterogeneous clinical presentation of immune checkpoint inhibitor-ass

220 The clinical presentation of infection due to serogroups C/W

221 Clinical presentation of LCV is variable and frequently

222 in neuronally derived exosomes predates the clinical presentation of Parkinson's disease (PD), offer

223 and the environment, and how these alter the clinical presentation of patients and their leukemias is

224 The clinical presentation of patients with different subtype

225 and mitral valve function in determining the clinical presentation of patients, and it allows charact

226 The clinical presentation of PIV in hospitalized adults vari

227 The clinical presentation of SBA was characterized by intest

228 ricians should recognise the early signs and clinical presentation of severe dengue, understand its p

229 the incidence of genetic predisposition and clinical presentation of sinusoidal obstructive syndrome

230 The clinical presentation of SLE is heterogeneous, can invol

231 Clinical presentation of TB patients is very diverse and

232 of causes other than breast cancer prior to clinical presentation of that cancer, for ductal carcino

233 photoreceptor loss were consistent with the clinical presentation of the affected siblings.

234 ovide a neurophysiological phenotype for the clinical presentation of this genetic deletion, but also

235 We present guidance on the clinical presentation of this spectrum and propose recom

236 Clinical presentations of BCG-related adverse reactions

237 In conclusion, the clinical presentations of HCC have significantly changed

238 can reliably diagnose the whole spectrum of clinical presentations of PJI.

239 ity of robust incidence data and spectrum of clinical presentations of the infection.

240 Although clinical presentations of these agents are similar, arth

241 Variation in clinical presentations of these diseases is often associ

242 f diagnosis is 3.4 years with a well-defined clinical presentation, older patients with KD including

243 l of bacteremia), in patients at the time of clinical presentation on IL-10 production and its associ

244 elevation in cardiac troponin at the time of clinical presentation or during the hospitalization.

245 well as genes that are more associated with clinical presentations or other genotypic markers.

246 ustment for potential confounders, including clinical presentation (OR [95% CI], 1.39 [0.90-2.15]; P=

247 een [(18)F]FEPPA VT and duration of illness, clinical presentation, or neuropsychological measures af

248 The clinical presentation overlaps with intellectual disabil

249 degenerative disorders that overlap in their clinical presentation, pathology and genetic origin.

250 recent advances in our understanding of its clinical presentation, pathomechanism and role of variou

251 sis of CNS is clearly related to the initial clinical presentation, pinpointing etiology remains chal

252 Adult RTD patients with MN had heterogeneous clinical presentations, potentially mimicking amyotrophi

253 We sought to characterize the clinical presentation, procedural characteristics, diagn

254 s themselves are also heterogeneous in their clinical presentation, progression, and pattern of neura

255 Clinical presentations range from self-limited disease t

256 Clinical presentation ranged from severe, neonatal-onset

257 affects millions of patients worldwide, with clinical presentation ranging from isolated thrombosis t

258 s that cause these individual differences in clinical presentation remain largely unknown.

259 We analyze trend in CPE incidence and clinical presentation, risk factors and local transmissi

260 Here, we review the epidemiology, clinical presentation, risk factors, diagnosis, treatmen

261 The clinical presentation runs a spectrum, ranging from head

262 1 RM that pheno-copies the severe congenital clinical presentation seen in a subgroup of RYR1 RM chil

263 architecture of anorexia nervosa mirrors its clinical presentation, showing significant genetic corre

264 2004 to 2015, in order to analyse aetiology, clinical presentation, spectrum of pathogens, and resolu

265 and l-tryptophan catabolism, associated with clinical presentations such as developmental delay, mild

266 thways exist across disorders with different clinical presentations, such as schizophrenia and autism

267 g white matter progressively increased after clinical presentation, suggesting not only a failure of

268 vCSF-cfmtDNA is associated with more severe clinical presentations; suggesting that it is associated

269 Preeclampsia is a syndrome with diverse clinical presentation that currently has no cure.

270 mature ventricular contractions are a common clinical presentation that drives further diagnostic wor

271 e dementia, characterized by a heterogeneous clinical presentation that includes three main subtypes:

272 osis is a complex disease with heterogeneous clinical presentations that can affect virtually any org

273 the study (2016-2019) on burden of disease, clinical presentation, the growing spread of drug-resist

274 rapeutic options are determined based on the clinical presentation, the location of the lesion, and p

275 er metabolism with considerable variation in clinical presentations, the most common ones being liver

276 Despite leading to similar clinical presentations, the underlying cardiac disease a

277 he predictive accuracy of host biomarkers at clinical presentation to the ED for adverse outcome.

278 sition should be tailored to the severity of clinical presentation, to comorbidities, and to the pote

279 OVID-19 among 10 SOT patients, including the clinical presentation, treatment modalities, and outcome

280 provide an analysis of the temporal trends, clinical presentation, treatment strategies, and in-hosp

281 s the current knowledge of the epidemiology, clinical presentation, treatment, and pathogenesis of th

282 ses and further on to humans, and the severe clinical presentation typical in these latter incidental

283 e disease where substantial heterogeneity in clinical presentation urgently requires a better stratif

284 Patient-level demographics, comorbidities, clinical presentation, utilization, complications, and m

285 Clinical presentation varied with age but not by serotyp

286 The clinical presentation varies between adults and children

287 ic presenting symptom of SIHD is angina, but clinical presentation varies greatly among patients.

288 ction (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract inf

289 The main clinical presentation was fever, without any specific pa

290 osed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory

291 Clinical presentation was mostly at birth with hypotonia

292 ion of genetic diagnosis in correlation with clinical presentation was obtained in all cases (COX20 n

293 Notably, the time from onset of symptom to clinical presentation was significantly longer [31(1-105

294 ich neurobiological variation might underlie clinical presentation, we obtained fMRI data from over 1

295 Etiologies and clinical presentations were similar between men living w

296 Greater CT and IT, at clinical presentation, were indicative of Gram-ve infect

297 Abnormal MRI findings, a clinical presentation with sensorimotor deficits, and a

298 infants during 2010 to 2016 and compare the clinical presentation with that of PeV-A3.

299 Coronavirus disease 2019 has markedly varied clinical presentations, with most patients being asympto

300 hat measuring mediators of these pathways at clinical presentation would identify febrile adults at r